DOI:
10.1055/s-00000133
Gastroenterologie up2date
LinksClose Window
References
Sands BE, Chen J, Feagan BG. et al.
Efficacy and safety of MEDI2070, an antibody against interleukin 23, in patients with moderate to severe Crohnʼs disease: a phase 2a study. Gastroenterol (epub ahead of print April 5, 2017).
Search in:
We do not assume any responsibility for the contents of the web pages of other providers.